FRIDAY, APRIL 17, 2020 | 3:00PM - 5:00PM CDT
CPPR Webinar
Comprehensive Physician and Practice Resuscitation Training
3:00pm – 3:05pm
3:05pm – 3:20pm
Dr. Devi interviews Kevin Pho on Evolving Role of Online Platforms during Pandemic – Kevin Pho, MD
3:20pm – 3:35pm
Overview of CPPR –
Laxmaiah Manchikanti, MD
3:35pm – 3:45pm
Financial Overview – Amol Soin, MD
3:45pm – 4:00pm
Ask CMS - Emily Yoder
Centers for Medicare and Medicaid Services
4:00pm – 4:15pm
Testing for Coronavirus and Antibodies: Value and Validity – Amit Mahajan, MD
3:00pm – 3:05pm
Insurance Issues; Business and Professional During and After Corona Pandemic.
Thomas Wierzbowski , Willow Risk Advisors
Christina Cassady ,Regional Manager, Risk Management, NORCAL Group
Nichole M. Pieters, MS, RN, CEN, CPHQ,
Senior Quality & Risk Management Specialist, NORCAL Group
4:30pm – 5:00pm
Open Forum Discussion Panel Panelists:
Devi Nampiaparampil, MD, Laxmaiah Manchikanti, MD, Amol Soin, MD, Amit Mahajan, MD, Christina Cassady, Nichole M. Pieters, MS, RN, CEN, CPHQ, Thomas Wierzbowski

Coronavirus destroys lungs. But doctors are finding its damage in kidneys, hearts and elsewhere
Coronavirus destroys lungs. But doctors are finding its damage in kidneys, hearts and elsewhere.

The new  coronavirus  kills by inflaming and clogging the tiny air sacs in the lungs, choking off the body’s oxygen supply until it shuts down the organs essential for life.

But clinicians around the world are seeing evidence that suggests the virus also may be causing heart inflammation, acute kidney disease, neurological malfunction, blood clots, intestinal damage and liver problems. That development has complicated treatment for the most severe cases of covid-19, the illness caused by the virus, and makes the course of recovery less certain, they said.
Dr. Devi Nampiaparampil Pens Book
Hospitals and healthcare workers struggle to keep up with the demand as the new coronavirus (COVID-19) spreads across the U.S. and throughout the world. 

Hundreds of millions of people are social distancing, quarantining, and sheltering in place to slow down the spread of the virus. The stock market is plunging and the global economy is heading into a recession because of the virus and because of the measures we are enforcing to stop it. Schools are closed. Restaurants, bars, and gyms are closed in many areas of the country. Major sports events, concerts and shows have been cancelled. Perhaps our greatest asset in this fight against the new coronavirus-- healthcare workers-- are becoming infected on the front lines. In the midst of this crisis, Doctor Devi explains what you need to know in a concise and easy-to-understand Question and Answer format.

Dr. Devi Nampiaparampil, a Harvard-trained doctor and a professor at NYU School of Medicine, breaks down the issues in this clear and compassionate handbook. What makes this virus so dangerous? How can I protect myself and my family? How did this happen?

For the latest guidelines, please always check:

Pain Physician March/April 
2020 Articles Available Online Now 
The March/April issue of Pain Physician  features 

Evolutionary Therapeutic Strategies
Sairam Atluri, MD, Laxmaiah Manchikanti, MD, and Joshua A. Hirsch, MD

Position Statement
Laxmaiah Manchikanti, MD, Christopher J. Centeno, MD, Sairam Atluri, MD, Sheri L. Albers, DO, Shane Shapiro, MD, Gerard A. Malanga, MD, Alaa Abd-Elsayed, MD, MPH, Mairin Jerome, MD, Joshua A. Hirsch, MD, Alan D. Kaye, MD, PhD, Steve M. Aydin, DO, Douglas Beall, MD, Don Buford, MD, Joanne Borg-Stein, MD, Ricardo Buenaventura, MD, Joseph A. Cabaret, MD, Aaron K. Calodney, MD, Kenneth D. Candido, MD, Cameron Cartier, MD, Richard Latchaw, MD, Sudhir Diwan, MD, Ehren Dodson, PhD, Zachary Fausel, MD, Michael Fredericson, MD, Christopher G. Gharibo, MD, Myank Gupta, MD, Adam M. Kaye, PharmD, FASCP, FCPhA, Nebojsa Nick Knezevic, MD, PhD, Radomir Kosanovic, MD, Matthew Lucas, DO, Maanasa V. Manchikanti , R. Amadeus Mason, MD, Kenneth Mautner, MD, Samuel Murala, MD, Annu Navani, MD, Vidyasagar Pampati, MSc, Sarah Pastoriza, DO, Ramarao Pasupuleti, MD, Cyril Philip, MD, Mahendra Sanapati, MD, Theodore Sand, PhD, Rinoo Shah, MD, Amol Soin, MD, Ian Stemper, MS, Bradley W. Wargo, DO, and Philippe Hernigou, MD

Health Policy Review
Laxmaiah Manchikanti, MD, Mahendra R. Sanapati, MD, Amol Soin, MD, Maanasa V. Manchikanti, BS, Vidyasagar Pampati, MSc, Vanila Singh, MD, and Joshua A. Hirsch, MD

Laxmaiah Manchikanti, MD, Mahendra R. Sanapati, MD, Vidyasagar Pampati, MSc, Amol Soin, MD, Sairam Atluri, MD, Alan D. Kaye, MD, PhD, Joysree Subramanian, MD, and Joshua A. Hirsch, MD

Sanjeeva Gupta, MD, and Manohar Sharma, MD
Push Needed for At-Home Coronavirus Antibody Testing
An opportunity for the U.S. to catch up

Now 12 weeks after the first case on United States soil of COVID-19 on Jan. 21, 2020, access to testing remains a challenge. South Korea and the United States reported their first cases on the same day; 6 weeks later, testing in South Korea was   1,900 per million residents versus 6 per million in the U.S . The result has been two-fold: individuals with COVID-19 are unknowingly transmitting infection to others and public health efforts at mitigation have been hampered by lack of reliable data.

Up until now testing for COVID-19 in the U.S. has largely relied on PCR assays of nasal swab collections by healthcare professionals. Scale-up efforts have been hampered by lack of testing capacity, as well as a shortage of nasal swab test kits. There is now a second option for testing: an antibody-based serology test that can be done with a pinprick blood test with results available at the point-of-care in 10-15 minutes. The antibody test can be used as a diagnostic for active infection (IgM antibodies), similar to a PCR test, and in addition, for assessing immunity from prior infection (IgG antibodies). This means antibody tests could be used to survey a population to determine cumulative infection and to allow certain individuals to return to work and partially lift stay-at-home orders.
Pain Management
Workgroup to Hold Evidence Review Advisory Meeting
Please find the letter   addressed to American Society of Interventional Pain Physicians, along with other pain organizations from the Pain Management Workgroup Evidence Review advisory meeting with important updates.
They are planning an evidence review advisory meeting for LCD policies on facet joint injections and medial nerve branch procedures. The meeting, which will be a combined meeting with all Medicare Administrative Contractors (MACs), is currently planned for May 28th in Nashville and as a teleconference. A link to the meeting and registration information will be posted to each MAC’s website and the CMS Landing Page within the next 2‐3 weeks.  ASIPP will be watching for this posting and will notify you so that you may register to attend.

Some of the ASIPP members are already serving on this committee; however, it is crucial that each state contact their own carriers and try to represent them. We need as many people as you can participate.
It is very crucial that you participate and understand. If you register you should be able to ask questions and give opinions, etc.
Please block your time for May 28 th from 1:00 to 3:00 pm CST.
THURSDAY, APRIL 23, 2020 | 5:00PM – 7:00PM CDT
CPPR Webinar
Comprehensive Physician and Practice Resuscitation Training
5:00pm – 5:05pm        Introduction
5:05pm – 5:20pm        CPPR Training – Laxmaiah Manchikanti, MD
5:20pm – 5:35pm        Getting Back to Normal: Scheduling – Testing – Shalini Shah, MD
5:35pm – 5:50pm        Revenue Cycle Management – Maharshi Patel
5:50pm – 6:15pm        Forming an IPA: Revolutionary or Reactionary – Ian Meyers
6:15pm – 6:30pm        Marketing During a Recession – Randy Alvaraez
6:30pm – 6:55pm        Open Forum Discussion
                                    Moderators: Laxmaiah Manchikanti, MD and Amol Soin, MD
WEDNESDAY, APRIL 29, 2020 | 5:00PM – 7:00PM CDT
CPPR Webinar
Comprehensive Physician and Practice Resuscitation Training
5:00 pm – 5:05pm        Introduction
5:05 pm – 5:20pm        Overview of Physician and Practice Rehabilitation –
Laxmaiah Manchikanti, MD
5:20pm – 5:35pm        Getting Back to Normal: Procedure Scheduling and Execution –
Shalini Shah, MD
5:35pm – 5:50pm        Revenue Cycle Management – Maharshi Patel
5:50pm – 6:15pm        Financial Rehabilitation: Fact Vs Fiction – Amol Soin, MD
6:15pm – 6:55pm        Open Forum Discussion
                                    Moderators: Laxmaiah Manchikanti, MD and Amol Soin, MD
Characteristics of Health Care Personnel with COVID-19
United States, February 12–April 9, 2020

What is already known about this topic?
Limited information is available about COVID-19 infections among U.S. health care personnel (HCP).

What is added by this report?
Of 9,282 U.S. COVID-19 cases reported among HCP, median age was 42 years, and 73% were female, reflecting these distributions among the HCP workforce. HCP patients reported contact with COVID-19 patients in health care, household, and community settings. Most HCP patients were not hospitalized; however, severe outcomes, including death, were reported among all age groups.

What are the implications for public health practice?
It is critical to ensure the health and safety of HCP, both at work and in the community. Improving surveillance through routine reporting of occupation and industry not only benefits HCP, but all workers during the COVID-19 pandemic.
HHS Pays Out First Round of CARES Act Funding to Hospitals
HHS is distributing $30B of the $100B in CARES Act funding
for healthcare providers using Medicare FFS revenue from 2019, the department announced.

 April 13, 2020 - HHS is starting to distribute the more than $100 billion in emergency funding from the Coronavirus Aid, Relief and Economic Security (CARES) Act, according to a recent  announcement .

The announcement on Friday stated that hospitals and other healthcare providers have started to receive $30 billion in payments. The first wave of emergency funding will go to hospitals based on Medicare revenue and will be directly deposited into provider bank accounts unless providers normally receive reimbursement via paper check.
FAQS about Families First Cornavirus Response Act and Coronavirus Aid, RELIEF, and Economic Security Act Implementation Part 42
Set out below are frequently asked questions (FAQs) regarding implementation of the Families First Coronavirus Response Act (the FFCRA), the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act), and other health coverage issues related to Coronavirus Disease 2019 (COVID-19). These FAQs have been prepared jointly by the Departments of Labor (DOL), Health and Human Services (HHS), and the Treasury (collectively, the Departments). Similar to previously issued FAQs (available at ), these FAQs answer questions from stakeholders to help individuals understand the law and benefit from it, as intended.
ASIPP ® Partners with Fedora Billing And Revenue Cycle
Management Company 
After long discussions, in addition to our NorCal liability program for ASIPP ® members, now we are able to offer unique benefits for revenue cycle management with billing, etc.

Fedora is a company known to many of our board members and others. ASIPP ® has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis. 

You may view the ASIPP ® billing program website at the following link:  

Some of the ASIPP ® Billing Program highlights are below:
Up to 50% savings for ASIPP ® members for their billing or revenue cycle management for their offices and surgery centers:
  • Expertise in interventional pain management billing for all types of services
  • 99% Clearing House Rate
  • 95% First-Time Claim Passage
  • 23.4 Average Days in A/R
  • Eligibility and Benefits Verification 
  • Pre-Certification/Prior Authorization
  • Denials and A/R Management 
Join The Group Purchasing Organization Today
ASIPP ® has formed a partnership with Henry Schein and PedsPal , a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.

It will be easy for  ASIPP ® members in good standing to enroll today and begin to realize the savings this partnership can bring. Members can join or see sample prices by going to   

Click on “view our discounted supplier prices” (Username:ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
Poor Communication During Referral Leads to Serious Repercussions 
Communication is extremely important, particularly in the field of medicine, and especially when more than one clinician is treating a patient. This month’s case involves a referral to another physician, – a situation where it is imperative that the referring physician provide all vital information about the patient’s condition to the one who is getting the referral. It is, however, equally important for the clinician getting the referral to do more than simply rely on the note from the referring physician.

In this case, the referring physician was Dr P, a psychiatrist. He had been treating the patient, Ms W, 38, for about a decade following two suicide attempts in her late 20’s. Ms W was being treated for depression, and was taking lorazepam and citalopram. For several months, Ms W had been complaining to Dr P about sleep issues, including difficulty sleeping and restless legs syndrome.
NIH Trial Evaluating Hydroxychloroquine for
COVID-19 Underway
A study evaluating the safety and effectiveness of hydroxychloroquine for the treatment of patients with coronavirus disease 2019 (COVID-19) has been initiated by the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network of the National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH).

The  ORCHID (Outcomes Related to COVID-19 treated with hydroxychloroquine among In-patients with symptomatic Disease) study  is a blinded, placebo-controlled randomized clinical trial that is expected to enroll 500 patients currently hospitalized with COVID-19 or those in the emergency department who will likely be hospitalized; the first participants have been enrolled at Vanderbilt University Medical Center in Tennessee. In addition to supportive care, patients in the intervention arm will receive hydroxychloroquine (oral or enteral dose of 400mg twice daily on the day of enrollment, then 200mg twice daily for the next 4 days for a 5 day total course).
Worrying About MOC During Pandemic? Don't
Specialty boards adjust exam schedules, ease deadlines, give credit for COVID-19 experience

The COVID-19 pandemic is leaving many doctors feeling overwhelmed, medical specialty boards are trying to ease doctors' burdens in at least one area: their certifications.

"Recognizing the unprecedented demands being placed on all of our board-certified physicians, ABIM [the American Board of Internal Medicine] wants to be sure you are able to maintain your certification despite the stresses you are facing," ABIM President and CEO Richard Baron, MD,  wrote Monday in a letter  to board-certified internists. "That's why today I am sharing an important update with you: No one will lose certification if they aren't able to complete a requirement this year. Any physician who is currently certified and has a Maintenance of Certification (MOC) requirement due in 2020 -- including an assessment, point requirement or attestation -- will now have until the end of 2021 to complete it. Physicians currently in their grace year will also be afforded an additional grace year in 2021."
FDA OKs Blood Purification System for COVID-19 Patients Admitted to ICU
The Food and Drug Administration (FDA) has issued an Emergency Use Authorization to Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge (Terumo BCT Inc. and Marker Therapeutics AG) for the treatment of patients 18 years of age or older with confirmed coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure to reduce proinflammatory cytokines levels. 

Cytokine levels are typically elevated during infections and can be associated with a cytokine storm in some COVID-19 patients. The Agency believes that the ability to manage the cytokine storm associated with COVID-19 may decrease patient morbidity. 
Essentials of Regenerative Medicine in Interventional
Pain Management
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.

Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
Essentials of Regenerative Medicine in Interventional Pain Management | ORDER |
Control Your Waiting Room TV

Customized waiting room TV exclusively for ASIPP ® members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
Registration to the OH/KY Meeting 2020 is Now Open! Click Here

Send in your state society meeting news to Holly Long ,
ASIPP ® | Pain Physician Journal | Phone | Fax | Email